Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.55%1.73B | 0.63%3.12B | 7.43%1.72B | 9.85%3.1B | 30.09%1.6B | 29.09%2.82B | 23.82%1.23B | 40.30%2.19B | 119.51%995.39M | -26.13%1.56B |
| Operating income | 0.55%1.73B | 0.63%3.12B | 7.43%1.72B | 9.85%3.1B | 30.09%1.6B | 29.09%2.82B | 23.82%1.23B | 40.30%2.19B | 119.51%995.39M | -26.13%1.56B |
| Operating expenses | -1.66%-1.45B | 5.64%-2.52B | -8.22%-1.43B | -23.88%-2.67B | -42.57%-1.32B | -31.55%-2.16B | -24.09%-925.77M | -47.64%-1.64B | -146.93%-746.06M | 27.25%-1.11B |
| Gross profit | -4.86%279.74M | 40.00%596.16M | 3.74%294.04M | -35.80%425.82M | -7.60%283.44M | 21.70%663.25M | 23.03%306.76M | 22.03%545M | 64.76%249.33M | -23.19%446.63M |
| Selling expenses | -16.47%-62.82M | 8.58%-119.22M | 31.39%-53.94M | -0.62%-130.41M | -32.58%-78.62M | -15.10%-129.6M | 0.38%-59.3M | -16.95%-112.6M | -111.82%-59.53M | 54.52%-96.28M |
| Administrative expenses | 21.42%-61.33M | 0.72%-171.02M | 0.09%-78.05M | 7.65%-172.26M | 6.03%-78.12M | -4.26%-186.52M | 2.35%-83.14M | -7.99%-178.9M | -4.41%-85.14M | 1.35%-165.67M |
| Research and development expenses | 38.22%-82.22M | 33.71%-237.95M | -9.60%-133.08M | -37.50%-358.95M | 15.37%-121.43M | -44.91%-261.05M | -67.68%-143.48M | -22.05%-180.15M | -34.58%-85.57M | -842.76%-147.6M |
| Profit from asset sales | -271.64%-305.47K | -100.05%-262.59K | 85.22%-82.19K | 196,750.89%500.85M | -299.62%-556.19K | -38.69%254.43K | 1,544.86%278.62K | 554.84%414.98K | -452.76%-19.28K | ---91.24K |
| Impairment and provision | -359.32%-19.15M | 111.17%14.86M | -112.72%-4.17M | -2,446.46%-133.02M | 626.11%32.77M | 109.26%5.67M | 40.35%-6.23M | -43.88%-61.19M | 45.16%-10.44M | 65.55%-42.53M |
| -Other impairment is provision | -359.32%-19.15M | 111.17%14.86M | -112.72%-4.17M | -2,446.46%-133.02M | 626.11%32.77M | 109.26%5.67M | 40.35%-6.23M | -43.88%-61.19M | 45.16%-10.44M | 65.55%-42.53M |
| Special items of operating profit | -49.42%16.56M | 301.55%51.53M | 268.84%32.74M | -60.31%12.83M | -51.91%8.88M | 19.98%32.33M | 71.93%18.46M | 219.80%26.95M | 67.04%10.74M | -89.45%8.43M |
| Operating profit | 20.03%61.06M | -11.45%106.97M | 36.17%50.87M | 14.81%120.8M | 57.59%37.36M | 433.43%105.21M | 157.48%23.7M | 244.56%19.72M | 121.85%9.21M | -109.57%-13.64M |
| Financing cost | -30.36%7M | 118.39%31.09M | -1.42%10.05M | -60.22%14.24M | -46.49%10.2M | 38.69%35.78M | 55.08%19.06M | 3.58%25.8M | 36.50%12.29M | --24.91M |
| Adjustment items of earning before tax | 226.87%836.54K | 19.37%2.45M | -80.10%255.92K | 111.85%2.05M | 2,037.15%1.29M | -1,667.12%-17.33M | 102.44%60.17K | -109.02%-980.76K | -332.06%-2.47M | --10.87M |
| Earning before tax | 12.61%68.9M | 2.50%140.51M | 25.26%61.18M | 10.85%137.09M | 14.05%48.84M | 177.62%123.67M | 125.07%42.82M | 101.22%44.54M | 159.32%19.03M | -84.48%22.14M |
| Tax | -1,210.97%-2.14M | -244.82%-11.66M | 105.11%192.91K | 200.74%8.05M | -235.70%-3.77M | -237.09%-7.99M | -254.36%-1.12M | 30,195.98%5.83M | -87.71%728.49K | 100.09%19.25K |
| After-tax profit from continuing operations | 8.77%66.75M | -11.23%128.85M | 36.18%61.37M | 25.48%145.14M | 8.08%45.07M | 129.62%115.67M | 111.08%41.7M | 127.36%50.38M | 175.55%19.75M | -81.86%22.16M |
| Earning after tax | 8.77%66.75M | -11.23%128.85M | 36.18%61.37M | 25.48%145.14M | 8.08%45.07M | 129.62%115.67M | 111.08%41.7M | 127.36%50.38M | 175.55%19.75M | -81.86%22.16M |
| Minority profit | 19.58%31.53K | 503.01%643.31K | -94.43%26.37K | 192.74%106.68K | --473.64K | --36.44K | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 8.76%66.72M | -11.60%128.21M | 37.57%61.35M | 25.42%145.04M | 6.94%44.59M | 129.54%115.64M | 111.08%41.7M | 127.36%50.38M | 175.55%19.75M | -81.86%22.16M |
| Basic earnings per share | 0.00%0.04 | -20.00%0.08 | 33.33%0.04 | 25.00%0.1 | 0.00%0.03 | 166.67%0.08 | 200.00%0.03 | 200.00%0.03 | 150.00%0.01 | -87.50%0.01 |
| Diluted earnings per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.